Abingdon Health PLC(GB:ABDX)
GBX 8.50-0.25 (-2.86%)
GB:ABDX
Abingdon Health PLC financials statements
GBX 8.50
At close:-0.25 (-2.86%)
Want to see GB:ABDX full AI Analyst Report?
Abingdon Health PLC (ABDX) Ratios
23 Followers
Abingdon Health PLC Ratios
GB:ABDX's free cash flow for Q4 2026 was £-479.00K. For the 2026 fiscal year, GB:ABDX's free cash flow was decreased by £-165.00K and operating cash flow was £-314.00K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.91 | 1.76 | 1.95 | 2.25 | 2.06 |
| Quick Ratio | 1.71 | 1.58 | 1.70 | 2.09 | 1.96 |
| Cash Ratio | 0.78 | 0.66 | 0.79 | 1.53 | 0.45 |
| Solvency Ratio | -0.30 | -0.70 | -0.30 | -0.91 | -3.10 |
| Operating Cash Flow Ratio | -0.44 | -1.06 | -0.91 | 0.47 | -1.45 |
| Short-Term Operating Cash Flow Coverage | -4.15 | -33.39 | 0.00 | 11.52 | -67.26 |
| Net Current Asset Value | £ 2.29M | £ 1.12M | £ 707.00K | £ 1.71M | £ 4.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.11 | 0.21 | 0.17 | 0.10 |
| Debt-to-Equity Ratio | 0.22 | 0.19 | 0.47 | 0.34 | 0.20 |
| Debt-to-Capital Ratio | 0.18 | 0.16 | 0.32 | 0.25 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.11 | 0.24 | 0.19 | 0.06 |
| Financial Leverage Ratio | 1.77 | 1.76 | 2.26 | 2.01 | 1.99 |
| Debt Service Coverage Ratio | -5.21 | -16.26 | -13.82 | -16.70 | -106.78 |
| Interest Coverage Ratio | -63.62 | -53.67 | -24.09 | -51.28 | -175.43 |
| Debt to Market Cap | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.71 | 0.29 | 0.43 | 0.79 | 0.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.10% | 37.11% | 59.97% | 34.66% | -184.44% |
| EBIT Margin | -26.04% | -44.25% | -21.87% | -86.50% | -759.22% |
| EBITDA Margin | -19.40% | -37.04% | -14.93% | -69.49% | -704.73% |
| Operating Profit Margin | -26.04% | -47.75% | -22.38% | -95.08% | -426.98% |
| Pretax Profit Margin | -18.39% | -45.14% | -22.80% | -88.36% | -764.90% |
| Net Profit Margin | -19.36% | -40.51% | -20.72% | -85.76% | -749.98% |
| Continuous Operations Profit Margin | -19.36% | -40.51% | -20.72% | -85.76% | -749.98% |
| Net Income Per EBT | 105.24% | 89.75% | 90.85% | 97.06% | 98.05% |
| EBT Per EBIT | 70.63% | 94.53% | 101.89% | 92.93% | 179.14% |
| Return on Assets (ROA) | -19.69% | -36.67% | -24.97% | -57.23% | -166.49% |
| Return on Equity (ROE) | -34.86% | -64.43% | -56.51% | -115.29% | -330.57% |
| Return on Capital Employed (ROCE) | -40.02% | -62.95% | -42.04% | -97.59% | -162.55% |
| Return on Invested Capital (ROIC) | -37.98% | -54.28% | -36.84% | -89.67% | -154.57% |
| Return on Tangible Assets | -26.15% | -52.31% | -27.89% | -58.10% | -166.96% |
| Earnings Yield | -5.01% | -13.31% | -4.07% | -9.51% | -66.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.24 | 3.14 | 5.66 | 3.68 | 0.34 |
| Payables Turnover | 1.78 | 6.93 | 4.06 | 2.38 | 3.26 |
| Inventory Turnover | 7.90 | 10.08 | 5.57 | 8.03 | 15.10 |
| Fixed Asset Turnover | 9.58 | 8.07 | 6.15 | 3.22 | 1.60 |
| Asset Turnover | 1.02 | 0.91 | 1.21 | 0.67 | 0.22 |
| Working Capital Turnover Ratio | 3.96 | 4.28 | 2.81 | 0.98 | 0.32 |
| Cash Conversion Cycle | -46.59 | 99.86 | 40.06 | -8.92 | 985.82 |
| Days of Sales Outstanding | 112.52 | 116.31 | 64.43 | 99.08 | 1073.50 |
| Days of Inventory Outstanding | 46.20 | 36.22 | 65.54 | 45.44 | 24.17 |
| Days of Payables Outstanding | 205.32 | 52.67 | 89.91 | 153.43 | 111.84 |
| Operating Cycle | 158.72 | 152.53 | 129.97 | 144.51 | 1097.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | 0.00 | -0.03 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | 0.00 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -8.41 | -9.50 | -40.46 | 6.38 | -10.18 |
| Capital Expenditure Coverage Ratio | -8.41 | -9.50 | -40.46 | 6.38 | -10.18 |
| Operating Cash Flow Coverage Ratio | -1.19 | -3.02 | -1.58 | 0.98 | -6.04 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.37 | -0.27 | 0.25 | -2.73 |
| Free Cash Flow Yield | -4.21% | -13.37% | -5.44% | 2.32% | -26.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -20.10 | -7.53 | -24.58 | -10.52 | -1.51 |
| Price-to-Sales (P/S) Ratio | 3.86 | 3.04 | 5.09 | 9.02 | 11.32 |
| Price-to-Book (P/B) Ratio | 6.96 | 4.84 | 13.89 | 12.12 | 4.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -23.76 | -7.48 | -18.37 | 43.18 | -3.78 |
| Price-to-Operating Cash Flow Ratio | -26.58 | -8.27 | -18.83 | 36.41 | -4.15 |
| Price-to-Earnings Growth (PEG) Ratio | 0.45 | -0.06 | 0.39 | 0.12 | -3.65 |
| Enterprise Value Multiple | -19.19 | -7.94 | -33.67 | -12.19 | -1.55 |
| Enterprise Value | 40.93M | 24.78M | 30.84M | 34.27M | 30.96M |
| EV to EBITDA | -19.19 | -7.94 | -33.67 | -12.19 | -1.55 |
| EV to Sales | 3.72 | 2.94 | 5.03 | 8.47 | 10.92 |
| EV to Free Cash Flow | -22.90 | -7.22 | -18.14 | 40.55 | -3.64 |
| EV to Operating Cash Flow | -25.63 | -7.98 | -18.59 | 34.20 | -4.00 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.05 | 0.10 | 0.09 | 0.03 | 0.02 |
| Revenue Per Share | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Net Income Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 |
| Tax Burden | 1.05 | 0.90 | 0.91 | 0.97 | 0.98 |
| Interest Burden | 0.71 | 1.02 | 1.04 | 1.02 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| SG&A to Revenue | 0.73 | 0.92 | 0.83 | 1.29 | 2.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.03 | 0.01 | 0.01 | 0.08 |
| Income Quality | 0.75 | 0.91 | 1.31 | -0.29 | 0.36 |
Currency in GBP
